Graham Capital Management, L.P. Genmab A/S Transaction History
Graham Capital Management, L.P.
- $4.38 Billion
- Q1 2025
A detailed history of Graham Capital Management, L.P. transactions in Genmab A/S stock. As of the latest transaction made, Graham Capital Management, L.P. holds 71,452 shares of GMAB stock, worth $1.63 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
71,452
Previous 55,417
28.94%
Holding current value
$1.63 Million
Previous $1.16 Million
21.02%
% of portfolio
0.03%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
66.2MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$336 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$130 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$116 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$101 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$65.8 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $15B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...